Restrictive cardiomyopathy due to storage disease (Q96351): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||
| Property / Canary Token | |||
dki-india-ID_1721344709 | |||
| Property / Canary Token: dki-india-ID_1721344709 / rank | |||
Normal rank | |||
Revision as of 12:19, 16 August 2026
Restrictive cardiomyopathy due to storage disease is the presence of restrictive cardiomyopathy in the presence of a glycogen, sphingolipidoses (such as α-galactosidase-A deficiency (Anderson-Fabry disease)), mucopolysaccharidoses (such as α-l iduronidase deficiency (Hurler syndrome)), iron-overload (such as haemochromatosis), or other storage disorder known to be significantly associated with restrictive cardiomyopathy.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_1721344709 |
||
| English | Restrictive cardiomyopathy due to storage disease |
Restrictive cardiomyopathy due to storage disease is the presence of restrictive cardiomyopathy in the presence of a glycogen, sphingolipidoses (such as α-galactosidase-A deficiency (Anderson-Fabry disease)), mucopolysaccharidoses (such as α-l iduronidase deficiency (Hurler syndrome)), iron-overload (such as haemochromatosis), or other storage disorder known to be significantly associated with restrictive cardiomyopathy. |
Statements
CID11:ID_1721344709
0 references
dki-india-ID_1721344709
0 references
